PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 213 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $296,518 | -22.2% | 7,400 | +8.8% | 0.00% | -25.0% |
| Q3 2021 | $381,000 | -16.3% | 6,800 | -9.3% | 0.00% | 0.0% |
| Q2 2021 | $455,000 | -13.5% | 7,500 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $526,000 | +20.4% | 7,500 | +2.7% | 0.01% | 0.0% |
| Q4 2020 | $437,000 | +32.0% | 7,300 | +32.7% | 0.01% | +25.0% |
| Q3 2020 | $331,000 | +17.0% | 5,500 | -15.4% | 0.00% | +33.3% |
| Q2 2019 | $283,000 | +14.6% | 6,500 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $247,000 | – | 6,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 550,000 | $18,442,000 | 6.98% |
| Gagnon Advisors, LLC | 193,860 | $6,500,000 | 6.06% |
| GAGNON SECURITIES LLC | 407,159 | $13,652,000 | 4.64% |
| Spyglass Capital Management LLC | 1,190,537 | $39,919,000 | 4.51% |
| Paulson & Co. | 1,716,727 | $57,562,000 | 2.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,627,521 | $54,571,000 | 1.73% |
| Elk Creek Partners, LLC | 265,146 | $8,890,000 | 1.53% |
| HealthCor Management, L.P. | 887,370 | $29,754,000 | 1.27% |
| Rock Springs Capital Management LP | 900,000 | $30,177,000 | 1.25% |
| Lisanti Capital Growth, LLC | 108,679 | $3,644,000 | 1.20% |